Search Results - "Kramchaninov, Mikhail M"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation by Moiseyenko, Fedor V., Egorenkov, Vitaliy V., Kramchaninov, Mikhail M., Artemieva, Elizaveta V., Aleksakhina, Svetlana N., Holmatov, Maxim M., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.

    Published in Case reports in oncology (01-05-2019)
    “…Vemurafenib has been developed to target common BRAF mutation V600E. It also exerts activity towards some but not all rare BRAF substitutions. Proper…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer by Fedyanin, M. Yu, Moiseenko, F. V., Chekini, D. A., Chubenko, V. A., Zhabina, A. S., Zagorskaya, L. A., Kramchaninov, M. M., Tjulandin, S. A., Moiseyenko, V. M.

    Published in Medicinskij sovet (21-12-2020)
    “…Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal…”
    Get full text
    Journal Article
  7. 7